PDF(Pubmed)
Abstract：
Thromboembolic events are the third leading cardiovascular diagnosis following stroke and myocardial infarction. In the United States, 300,000 to 600,000 people per year are diagnosed with venous thromboembolism, either deep venous thrombosis or pulmonary embolism (PE). Of those patients, thousands die from PE despite heightened vigilance and improved therapies. Lung transplant recipients are at increased risk of developing PE due to multiple risk factors unique to this population. Additionally, the transplant recipients are more susceptible to morbid complications from PE. As a result, prevention, timely recognition, and intervention of PE in the lung transplant population are of the utmost importance.
摘要：
血栓栓塞事件是中风和心肌梗死后的第三大心血管诊断。在美国,每年有30万至60万人被诊断患有静脉血栓栓塞症，深静脉血栓形成或肺栓塞（PE）。这些病人中,尽管提高了警惕性和改善了治疗方法，但仍有数千人死于PE。由于该人群特有的多种风险因素，肺移植受者患PE的风险增加。此外,移植受者更容易发生PE的病态并发症.因此,预防,及时识别,肺移植人群中PE的干预至关重要。
